Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”
Yingzhe Zhang. Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”. // Hepatology Research. – 2026. – DOI: 10.1111/hepr.70227. – URL: https://onlinelibrary.wiley.com/doi/10.1111/hepr.70227?af=R
Yingzhe Zhang (2026). Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”. Hepatology Research. https://doi.org/10.1111/hepr.70227
Yingzhe Zhang. “Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”.” Hepatology Research, 2026. doi:10.1111/hepr.70227.
@article{Zhang2026,
title = {Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”},
author = {Zhang, Yingzhe},
journal = {Hepatology Research},
year = {2026},
doi = {10.1111/hepr.70227},
url = {https://onlinelibrary.wiley.com/doi/10.1111/hepr.70227?af=R}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...